Today, on Rare Disease Day, VIVEbiotech stands in solidarity with the 300 million people worldwide who live with a rare disease, along with their families and caregivers.
At VIVEbiotech, we take pride in the fact that 20% of our projects are dedicated to supporting customers working on treatments for rare diseases. With more than 6,000 rare diseases identified—72% of them genetic and 70% beginning in childhood—the need for continued research, improved treatments, and, most importantly, hope, has never been greater.
This year, in addition to our contributions to scientific advancements, we wanted to highlight the human side of our work. To do so, we collaborated with Algaraklown, a remarkable non-profit organization that uses humor as a therapeutic tool in various settings. One of their most meaningful initiatives involves visiting the Maternal and Pediatric Unit of the Hospital Universitario de San Sebastián, where their dedicated clowns bring joy and emotional support to children in oncology, pediatric ICU, neonatology, and other hospital areas.
To commemorate this day, our team at VIVEbiotech came together, holding balloons in the colors of Rare Disease Day and wearing Algaraklown’s solidarity clown noses —symbols of our commitment to the real impact our work has on patients’ lives.
At VIVEbiotech, we believe that every step forward in gene therapy, every breakthrough in rare disease research, brings us closer to transforming lives. Today, we reaffirm our dedication to making that change a reality.